Cargando…
Cancer Cachexia: Traditional Therapies and Novel Molecular Mechanism-Based Approaches to Treatment
The complex syndrome of cancer cachexia (CC) that occurs in 50% to 80% cancer patients has been identified as an independent predictor of shorter survival and increased risk of treatment failure and toxicity, contributing to the mortality and morbidity in this population. CC is a pathological state...
Autores principales: | Kumar, Nagi B., Kazi, Aslam, Smith, Tiffany, Crocker, Theresa, Yu, Daohai, Reich, Richard R., Reddy, Kiran, Hastings, Sally, Exterman, Martine, Balducci, Lodovico, Dalton, Kyle, Bepler, Gerold |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016925/ https://www.ncbi.nlm.nih.gov/pubmed/21128029 http://dx.doi.org/10.1007/s11864-010-0127-z |
Ejemplares similares
-
Does COVID‐19‐related cachexia mimic cancer‐related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management
por: Kumar, Nagi B.
Publicado: (2021) -
A Method for Biomarker Directed Survival Prediction in Advanced Non-Small-Cell Lung Cancer Patients Treated with Carboplatin-Based Therapy
por: Chen, Wei, et al.
Publicado: (2013) -
Release of ATP in the central nervous system during systemic inflammation: real-time measurement in the hypothalamus of conscious rabbits
por: Gourine, Alexander V, et al.
Publicado: (2007) -
Increased maternofetal calcium flux in parathyroid hormone-related protein-null mice
por: Bond, H, et al.
Publicado: (2008) -
Contribution of α(2)-adrenoceptors and Y(1) neuropeptide Y receptors to the blunting of sympathetic vasoconstriction induced by systemic hypoxia in the rat
por: Coney, Andrew M, et al.
Publicado: (2007)